SIOX - Sio Gene Therapies GAAP EPS of -$0.04 beats by $0.15 November, 10 2022 08:43 AM Sio Gene Therapies Inc. Sio Gene Therapies press release ( NASDAQ: SIOX ): Q2 GAAP EPS of -$0.04 beats by $0.15 . As of September 30, 2022, Company had $49.86 million of cash and cash equivalents. For further details see: Sio Gene Therapies GAAP EPS of -$0.04 beats by $0.15